RAPT Therapeutics (RAPT) Earnings Date, Estimates & Call Transcripts $0.79 -0.01 (-1.32%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.78 -0.01 (-1.08%) As of 04/17/2025 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RAPT Therapeutics Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Mar. 6) -$0.45 Actual EPS (Mar. 6) -$1.14 Missed By -$0.69 RAPT Therapeutics issued Q4 2024 earnings on March 6, 2025, reporting an EPS of -$1.14, which missed the consensus estimate of -$0.45 by $0.69. With a trailing EPS of -$3.11, RAPT Therapeutics' earnings are expected to grow next year, from ($2.14) to ($1.35) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)RAPT Upcoming EarningsRAPT Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get RAPT Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on RAPT Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRAPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RAPT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. RAPT Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.16-$0.16-$0.16Q2 20251-$0.18-$0.18-$0.18Q3 20251-$0.20-$0.20-$0.20Q4 20251-$0.22-$0.22-$0.22FY 20254($0.76)($0.76)($0.76) RAPT Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------3/6/2025Q4 2024-$0.45-$1.14 -$0.69-$1.14--11/12/2024--$0.56-$0.47+$0.09-$0.47--8/8/2024--$0.74-$0.71+$0.03-$0.71--5/9/2024Q1 2024-$0.78-$0.79 -$0.01-$0.79--3/7/2024Q4 2023-$0.85-$0.80+$0.05-$0.80--11/13/2023Q3 2023-$0.75-$0.82 -$0.07-$0.82--8/11/2023Q2 2023-$0.78-$0.66+$0.12-$0.66--5/11/2023Q1 2023-$0.64-$0.76 -$0.12-$0.76-- RAPT Therapeutics Earnings - Frequently Asked Questions When is RAPT Therapeutics's earnings date? RAPT Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on RAPT's earnings history. Did RAPT Therapeutics beat their earnings estimates last quarter? In the previous quarter, RAPT Therapeutics (NASDAQ:RAPT) missed the analysts' consensus estimate of ($0.45) by $0.69 with a reported earnings per share (EPS) of ($1.14). Learn more on analysts' earnings estimate vs. RAPT's actual earnings. How much revenue does RAPT Therapeutics generate each year? RAPT Therapeutics (NASDAQ:RAPT) has a recorded annual revenue of $1.53 million. How much profit does RAPT Therapeutics generate each year? RAPT Therapeutics (NASDAQ:RAPT) has a recorded net income of -$116.80 million. RAPT has generated -$3.11 earnings per share over the last four quarters. What is RAPT Therapeutics's EPS forecast for next year? RAPT Therapeutics's earnings are expected to grow from ($2.14) per share to ($1.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies UroGen Pharma Earnings Results Ginkgo Bioworks Earnings Results GH Research Earnings Results Kura Oncology Earnings Results CorMedix Earnings Results Sage Therapeutics Earnings Results Cullinan Therapeutics Earnings Results Maravai LifeSciences Earnings Results Tyra Biosciences Earnings Results SIGA Technologies Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:RAPT) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen your...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RAPT Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RAPT Stock Free RAPT Stock Alerts